Skip to main content

Advertisement

Log in

Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients

  • Original Article – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to evaluate the prognostic influence of epithelial cell adhesion molecule (EpCAM) in an unselected cohort of ovarian cancer (OC) patients.

Methods

Expression of EpCAM was determined by immunohistochemistry in an unselected cohort of 117 patients with OC. Univariable and multivariable Cox regression analyses adjusted for age, tumor stage, histological grading, histological subtype, postoperative tumor burden and completeness of chemotherapy were performed in order to determine the prognostic influence of EpCAM. The Kaplan–Meier method is used to estimate survival rates.

Results

Univariable Cox regression analysis showed that overexpression of EpCAM is associated with favorable prognosis in terms of progression-free survival (PFS) (p = 0.011) and disease-specific survival (DSS) (p = 0.003). In multivariable Cox regression analysis, overexpression of EpCAM retains its significance independent of established prognostic factors for longer PFS [hazard ratios (HR) 0.408, 95 % confidence interval (CI) 0.197–0.846, p = 0.003] but not for PFS (HR 0.666, 95 % CI 0.366–1.212, p = 0.183). Kaplan–Meier plots demonstrate an influence on 5-year PFS rates (0 vs. 27.6 %, p = 0.048) and DSS rates (11.8 vs. 54.0 %, p = 0.018).

Conclusions

These findings support the hypothesis that the expression of EpCAM is associated with favorable prognosis in OC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S et al (2011) Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 30:3468–3476

    Article  CAS  PubMed  Google Scholar 

  • Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS et al (1998) Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90:691–697

    Article  CAS  PubMed  Google Scholar 

  • Battista MJ, Mantai N, Sicking I, Cotarelo C, Weyer V, Lebrecht A, Solbach C, Schmidt M (2014) Ki-67 as independent prognostic factor in an unselected cohort of patients with ovarian cancer—results of an explorative, retrospective study. Oncol Rep 31:2213–2219

    PubMed  Google Scholar 

  • Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519–2529

    Article  CAS  PubMed  Google Scholar 

  • Gadducci A, Cosio S, Tana R, Genazzani AR (2009) Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 69:12–27

    Article  PubMed  Google Scholar 

  • Gastl G, Spizzo G, Obrist P, Dünser M, Mikuz G (2000) Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356:1981–1982

    Article  CAS  PubMed  Google Scholar 

  • Ghebeh H, Sleiman GM, Manogaran PS, Al-mazrou A, Barhoush E, Al-mohanna FH et al (2013) Profiling of normal and malignant breast tissue show CD44 high/CD24 low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer 13:289

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357

    Article  CAS  PubMed  Google Scholar 

  • Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ et al (2004) Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10:4427–4436

    Article  CAS  PubMed  Google Scholar 

  • Jojović M, Adam E, Zangemeister-Wittke USU (1998) Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial–mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice. Histochem J 30:732–739

    Google Scholar 

  • Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y et al (2007) Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol 30:171–179

    CAS  PubMed  Google Scholar 

  • Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO (1994) Ep-CAM: a human epithelial antigen is a homophilic cell–cell adhesion molecule. J Cell Biol 125:437–446

    Article  CAS  PubMed  Google Scholar 

  • Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F et al (1997) Epithelial cell adhesion molecule (Ep-CAM) modulates cell–cell interactions mediated by classic cadherins. J Cell Biol 139:1337–1348

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O (2004) The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23:5748–5758

    Article  PubMed  Google Scholar 

  • Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA et al (2004) EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64:5818–5824

    Article  CAS  PubMed  Google Scholar 

  • Pietzner K, Woopen H, Richter R, Joens T, Braicu EI, Dimitrova D, Mellstedt H, Darb-Esfahani S, Denkert C, Lindhofer H, Fotopoulou CSJ (2013) Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer. Int J Gynecol Cancer 23:797–802

    Article  PubMed  Google Scholar 

  • Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46:685–693

    Article  CAS  PubMed  Google Scholar 

  • Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE (2009) Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 69:753–757

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E et al (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849–5855

    Article  CAS  PubMed  Google Scholar 

  • Schmidt M, Petry IB, Böhm D, Lebrecht A, Von Törne C, Gebhard S et al (2011) Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat 125:637–646

    Article  CAS  PubMed  Google Scholar 

  • Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MHT et al (2004) Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10:2659–2669

    Article  CAS  PubMed  Google Scholar 

  • Shim HS, Yoon BS, Cho NH (2009) Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. Hum Pathol 40:693–698

    Article  CAS  PubMed  Google Scholar 

  • Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 2014(64):9–29

    Article  Google Scholar 

  • Songun I, Litvinov SV, Van de Velde CJH, Pals ST, Hermans J, Van Krieken JHJM (2005) Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92:1767–1772

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Bäuerle PA et al (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103:483–488

    Article  CAS  PubMed  Google Scholar 

  • Stoecklein NH, Siegmund A, Scheunemann P, Luebke AM, Erbersdobler A, Verde PE et al (2006) Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer 6:165

    Article  PubMed Central  PubMed  Google Scholar 

  • Tai K-Y, Shiah S-G, Shieh Y-S, Kao Y-R, Chi C-Y, Huang E et al (2007) DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 26:3989–3997

    Article  CAS  PubMed  Google Scholar 

  • Varga M, Obrist P, Schneeberger S, Mu G, Felgel-farnholz C, Fong D et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Parts of the here presented results derive from the doctoral thesis of Ms. Sina Jakobi.

Conflict of interest

The authors state that no conflicts of interests are to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Johannes Battista.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Battista, M.J., Cotarelo, C., Jakobi, S. et al. Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients. J Cancer Res Clin Oncol 140, 1097–1102 (2014). https://doi.org/10.1007/s00432-014-1672-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-014-1672-9

Keywords

Navigation